Stable expression of transgene-encoded enhanced green fluorescence protein (eGFP) was used as a sensitive and specific marker to detect in situ donor cells engrafted into different tissues of adoptive hosts. eGFP ؉ lymphoid or myeloid cells (eg, CD4 ؉ T cells or bone marrow-derived dendritic cells) from eGFPtransgenic C57BL/6 donor mice were injected into congenic, immunodeficient RAG1 ؊/؊ C57/BL6 hosts. eGFP ؉ cells were detected in the adoptive host from 2 days to 4 weeks after transfer using an optimized method of fixed cryopreservation to process the tissue. This allowed the simple, sensitive, and specific detection of eGFP ؉ donor cells in histological sections of transplanted hosts. We further demonstrate that this technique can be combined with other estab- have low sensitivity (often caused by high background reactivity of the tissue of interest), and may have limited specificity because of cross-reactivities with host cells that are difficult to control. The availability of monoclonal antibodies (mAbs) suitable for immunohistology in the murine system is limited. Hence, simple and specific techniques to identify in situ engrafted cells and to simultaneously determine their differentiation, activation, and viability status would greatly facilitate many studies in vivo.Green fluorescent protein (GFP) is a bioluminescent protein from the jellyfish Aequorea victoria. 3,4 Mutant variants of this protein have been developed that show enhanced fluorescence. A commonly used variant with enhanced fluorescence is GFPmut1 (designated eGFP in this article). 5 eGFP has been used as a reporter gene in prokaryotic and eukaryotic cells in vitro. A transgenic C57BL/6 mouse line has been constructed that expresses eGFP under the chicken -actin promoter control. 6 -10 These mice have been used to study hemopoietic and lymphoid development, 11-13 spermatogenesis, 14 and maternal cell transmission to offspring through placenta during pregnancy and by breast-feeding after birth. 15 These studies required the isolation of viable cells from the host and their subsequent flow cytometric identification and characterization. Because of the lack of optimized techniques to detect eGFP-expressing cells in situ, an analysis of cell migration, proliferation, and differentiation by immunohistological techniques was difficult to perform in this attractive model.We transferred eGFP ϩ cells of well-defined lymphoid or myeloid subsets, ie, splenic CD4 ϩ T cells or bone marrow-derived dendritic cells (DCs), from eGFP-transgenic (eGFP-tg) C57/BL6 (B6) donor mice into congenic, immunodeficient RAG1 Ϫ/Ϫ B6 hosts. We used the stable expression of eGFP as a sensitive and highly specific